| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | €15.66B | 4.72 | 10.50% | 6.45% | -10.26% | 28.54% | |
62 Neutral | €2.09B | 9.46 | 4.83% | 4.18% | -13.80% | -45.00% | |
61 Neutral | €496.36M | 5.55 | 7.22% | 2.31% | 3.60% | -9.53% | |
56 Neutral | €305.39M | 12.22 | 2.68% | ― | -8.69% | -5.22% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | €180.05M | 3.78 | 6.04% | 2.83% | -8.67% | -31.83% | |
42 Neutral | €85.95M | -18.44 | 0.35% | 7.08% | -3.55% | 3378.81% |